MYRIAD GENETICS INC — Director's Dealing 2020

Sep 25, 2020

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2020-09-24

Reporting Person: Hart Jayne B. (Executive VP Human Resources)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	57267	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Incentive Stock Option (right to buy)	$23.98	2022-03-07	Common Stock (3500)		Direct
Incentive Stock Option (right to buy)	$24.89	2021-05-25	Common Stock (8034)		Direct
Incentive Stock Option (right to buy)	$26.49	2021-09-17	Common Stock (3775)		Direct
Incentive Stock Option (right to buy)	$27.07	2022-09-12	Common Stock (593)		Direct
Non-Qualified Stock Option (right to buy)	$19.47	2021-09-13	Common Stock (28000)		Direct
Non-Qualified Stock Option (right to buy)	$23.98	2022-03-07	Common Stock (7000)		Direct
Non-Qualified Stock Option (right to buy)	$24.89	2021-05-25	Common Stock (21966)		Direct
Non-Qualified Stock Option (right to buy)	$26.49	2021-09-17	Common Stock (73225)		Direct
Non-Qualified Stock Option (right to buy)	$27.07	2022-09-12	Common Stock (51907)		Direct

Footnotes

F1: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest and become exercisable 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.